Correlation Between Axsome Therapeutics and Incyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Incyte, you can compare the effects of market volatilities on Axsome Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Incyte.

Diversification Opportunities for Axsome Therapeutics and Incyte

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Axsome and Incyte is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Incyte go up and down completely randomly.

Pair Corralation between Axsome Therapeutics and Incyte

Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 1.47 times less return on investment than Incyte. But when comparing it to its historical volatility, Axsome Therapeutics is 1.38 times less risky than Incyte. It trades about 0.15 of its potential returns per unit of risk. Incyte is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  6,569  in Incyte on August 28, 2024 and sell it today you would earn a total of  783.00  from holding Incyte or generate 11.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Axsome Therapeutics  vs.  Incyte

 Performance 
       Timeline  
Axsome Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Incyte 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Incyte are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Incyte showed solid returns over the last few months and may actually be approaching a breakup point.

Axsome Therapeutics and Incyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axsome Therapeutics and Incyte

The main advantage of trading using opposite Axsome Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.
The idea behind Axsome Therapeutics and Incyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation